Asthenia: Difference between revisions
Shanshan Cen (talk | contribs) |
|||
Line 42: | Line 42: | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Heart disease]] | ||
|- | |- | ||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | |bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | ||
Line 57: | Line 57: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Acamprosate calcium]], [[Adefovir]], [[Aprepitant]], [[Atovaquone-Proguanil]], [[Bicalutamide]], [[Busulfan]], [[Cefaclor]], [[Dalfampridine]], [[Desmopressin]], [[Docetaxel]], [[Efavirenz]], [[Enzalutamide]], [[Eribulin]], [[Eslicarbazepine acetate]], [[Fluvoxamine]],[[Fosfomycin]], [[Fulvestrant]], [[Granisetron]], [[Interferon alfa-2b ]], [[Pegylated interferon alfa-2a]], [[Irinotecan hydrochloride]], [[Meropenem]], [[Nabilone]], [[Netupitant and palonosetron]], [[Oxaprozin]], [[Palbociclib]], [[Panitumumab]], [[Perampanel]], [[Pilocarpine]], [[Pyridostigmine]], [[Ribavirin]], [[Ritonavir]], [[Sargramostim]], [[Sunitinib]], [[Temozolomide]], [[Teniposide]] | |bgcolor="Beige"| [[Chemotherapy]], [[Narcotics]], [[Acamprosate calcium]], [[Adefovir]], [[Aprepitant]], [[Atovaquone-Proguanil]], [[Bicalutamide]], [[Busulfan]], [[Cefaclor]], [[Dalfampridine]], [[Desmopressin]], [[Docetaxel]], [[Efavirenz]], [[Enzalutamide]], [[Eribulin]], [[Eslicarbazepine acetate]], [[Fluvoxamine]],[[Fosfomycin]], [[Fulvestrant]], [[Granisetron]], [[Interferon alfa-2b ]], [[Pegylated interferon alfa-2a]], [[Irinotecan hydrochloride]], [[Meropenem]], [[Nabilone]], [[Netupitant and palonosetron]], [[Oxaprozin]], [[Palbociclib]], [[Panitumumab]], [[Perampanel]], [[Pilocarpine]], [[Pyridostigmine]], [[Ribavirin]], [[Ritonavir]], [[Sargramostim]], [[Sunitinib]], [[Temozolomide]], [[Teniposide]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 65: | Line 65: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Addison's disease]], [[Diabetes]], [[Hypothyroidism]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 81: | Line 81: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Anemia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Chemotherapy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Infections]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 97: | Line 97: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Chronic fatigue syndrome]], [[Chronic pain]], [[Sleep disorders]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Diabetes]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Pregnancy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Chemotherapy]], [[Paraneoplastic syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 117: | Line 117: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Narcotics]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Anxiety]], [[Chronic fatigue syndrome]], [[Depression]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Pulmonary disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Dehydration and electrolyte disturbance]], [[Renal disease]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Fibromyalgia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 149: | Line 149: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Sedentary lifestyle]], [[Sleep disorders]] | ||
|- | |- | ||
|} | |} |
Revision as of 16:47, 27 October 2016
Asthenia | |
ICD-10 | R53 |
---|---|
ICD-9 | 780.7 |
Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Asthenia (Greek: ασθένεια, lit. lack of strength but also disease) is a medical term denoting a feeling of weakness without actual loss of strength.
Causes of asthenia
The condition is commonly seen in patients suffering from chronic fatigue syndrome, sleep disorders or chronic disorders of the heart, lungs or kidneys. Differentiating between asthenia and true muscular weakness is often difficult, and in time asthenia in chronic disorders is seen to progress into a primary weakness. Also a condition in which the body lacks or has lost strength either as a whole or in any of its parts. General asthenia occurs in many chronic wasting diseases, such as anemia and cancer, and is probably most marked in diseases of the adrenal gland. Asthenia may be limited to certain organs or systems of organs, as in asthenopia, characterized by ready fatiguability.
Common causes of asthenia
- Addison's disease
- Anemia
- Anxiety
- Chemotherapy
- Chronic fatigue syndrome
- Chronic pain
- Deconditioning / sedentary lifestyle
- Dehydration and electrolyte disturbance
- Drugs- Botulinum toxin, Metformin, Paroxetine
- Depression
- Diabetes
- Fibromyalgia
- Heart disease
- Hypothyroidism
- Infections
- Medications including amiodarone, conjugated estrogen, caspofungin acetate
- Narcotics
- Paraneoplastic syndrome
- Pregnancy/postpartum
- Pulmonary disease
- Renal disease
- Sleep disorders
Causes by Organ System
Causes in Alphabetical Order
See also
References
- Adapted from: Hinshaw DB, Carnahan JM, Johnson DL. Depression, anxiety, and asthenia in advanced illness. J Am Coll Surg 2002;195:276.